Notes to Consolidated Financial Statements

For the years ended December 31, 2014 and 2013

  1. Cameco Corporation
  2. Significant accounting policies
  3. Accounting standards
  4. Determination of fair values
  5. Use of estimates and judgments
  6. Discontinued operation
  7. Acquisitions
  8. Accounts receivable
  9. Inventories
  10. Property, plant and equipment
  11. Goodwill and intangible assets
  12. Long-term receivables, investments and other
  13. Equity-accounted investees
  14. Accounts payable and accrued liabilities
  15. Short-term debt
  16. Long-term debt
  17. Other liabilities
  1. Provisions
  2. Share capital
  3. Employee benefit expense
  4. Finance costs
  5. Other income (expense)
  6. Income taxes
  7. Per share amounts
  8. Statements of cash flows
  9. Share-based compensation plans
  10. Pension and other post-retirement benefits
  11. Financial instruments and related risk management
  12. Capital management
  13. Segmented information
  14. Group entities
  15. Joint operations
  16. Related parties
  17. Subsequent event

17. Other liabilities

  2014  2013 
Deferred sales $123,298  $55,126 
Derivatives [note 28] 67,916  30,923 
Accrued pension and post-retirement benefit liability [note 27] 61,670  45,931 
Other 7,033  8,085 
  259,917  140,065 
Less current portion (87,883) (60,685)
Net $172,034  $79,380 

Deferred sales includes $92,299,000 (US) (2013 – $36,725,000 (US)) of performance obligations relating to financing arrangements entered into by NUKEM (note 9).